Wound infection in the management of hip fractures: A comparison between low-molecular weight heparin and mechanical prophylaxis

Acta Orthopaedica Belgica

Volumn 71, Issue 1, 2005, Pages 55-59

  Sanchez Ballester, Jordi ^a,b   Smith, Mathew ^a   Hassan, Kamran ^a   Kershaw, Steven ^a   Elsworth, Chris S ^a   Jacobs, Leo ^a  

^a ROYAL OLDHAM HOSPITAL   (United Kingdom)

^b Royal Oldham Hospital ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; COMPARATIVE STUDY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; FEMALE; FEMUR NECK; HIGH RISK PATIENT; HIP FRACTURE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; BIOMECHANICS; BONE SCREWS; FEMALE; FEMORAL NECK FRACTURES; FIBRINOLYTIC AGENTS; FRACTURE FIXATION; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; VENOUS THROMBOSIS;

EID: 14844315752     PISSN: 00016462     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Dee R, Hurst L. Principles of Orthopaedic Practice. Second Edition, pp 863.
2. Department of Health. Hospital Episode Statistics. England: Financial Year 1990-1991. HMSO, 1994. 1 (London).
3. Freedman KB, Brookenthal KR, Fitzgerald RH Jr et al. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg 2000; 82-A: 929-938.
4. Gerber C, Strehle J, Ganz R. The treatment of fractures of the femoral neck. Clin Orthop 1993; 292: 77-78.
5. Harris WH, Salzman EW, Athanasoulis C et al. Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement. J Bone Joint Surg 1974; 56-A: 1552-1562.
6. Lotke PA, Ecker ML, Alavi A, Berkowitz H. Indications for the treatment of deep venous thrombosis following total knee replacement. J Bone Joint Surg 1984; 66-A: 202-208.
7. Patterson BM, Marchand R, Ranawat C. Complications of heparin therapy after total joint arthroplasty. J Bone Joint Surg 1989; 71-A: 1130-1134.
8. PEP Trial collaborative group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000; 355: 1295-1302.
9. Wilson AP, Webster A, Gruneberg RN et al. A scoring method (ASEPSIS) for postoperative wound infections for use in clinical trials of antibiotic prophylaxis. Lancet 1986, 1: 311-313.